Texas Capital Bancshares in Dallas continues to reshape its balance sheet.
The $29.9 billion-asset company said in a press release that it bought a $400 million portfolio of committed exposure to the healthcare sector and sold $1.2 billion of securities at a $139 million after-tax loss.
Texas Capital said it expects to report a net loss in the third quarter due to the securities sales.
The proceeds from the securities sales were used to buy roughly $1.1 billion of higher-yielding securities that should generate $35 million to $40 million of net interest income on an annualized basis.
“Three years after announcing our strategic plan, we are pleased with the tremendous progress made building a balance sheet and a business model worthy of serving the best clients in our markets,” Rob Holmes, Texas Capital’s CEO, said in the release.
“Actions announced today represent another deliberate step in translating observed strategic success into targeted financial performance associated with long-term value creation,” he added. “We remain focused on delivering exceptional results for clients and shareholders by leveraging our differentiated platform.”
The company also took measures to reduce 2025 operating expenses by $30 million.